LIFEAI LTD

What LIFEAI LTD does

LIFE AI operates the Biohub, an AI-native infrastructure layer for human health that integrates genetic data, biomarkers, lifestyle factors, and clinical outcomes across a single platform. Founded in 2017 by former Google engineering leader Dr. Tuan Cao, the company is legally organized as the LIFE AI Foundation, a non-profit incorporated in Singapore with operational headquarters in San Francisco. The platform accesses health trajectories from 550,000+ humans in natural living conditions (15+ petabytes of data) and serves pharmaceutical companies, hospitals, research institutions, and individual consumers across the United States and six Asian countries (Korea, Hong Kong, Singapore, Indonesia, Thailand, Vietnam).

The Biohub architecture combines AI capabilities, blockchain-secured data sovereignty (Gene NFTs and Trusted Execution Environments), and a modular subnet system spanning Genetica (genetic testing), Prevana (preventive healthcare), Life Cloud (data infrastructure), Life Unity (community engagement), and InfiniteLife (longevity). The LIFE App serves as the consumer-facing super-app reaching 112,000+ users. Validated enterprise outcomes include compressing stroke-prevention product development from 24 months to 6 weeks (Kalbe Farma StrokeGENME), reducing an autism genetics study cost from $250K to $10K (Hue Central Hospital), and accelerating Parkinson's drug discovery by 40% via AI-driven in-silico design. Scientific credibility is supported by research collaborations with Stanford, Cornell, and UCSF and a top-tier journal publication.

Revenue derives from four streams: enterprise infrastructure partnerships (managed-services and co-development with pharma and hospital networks), AI Model-as-a-Service subscriptions, one-time genetic testing fees routed through licensed partner Genetica, and freemium consumer membership (VIP tier earned via three genetic test purchases, unlocking a 30% discount). Distribution combines enterprise field sales, healthcare provider networks (VMA Thailand), wellness platform integrations, and the LIFE App direct channel. Total disclosed funding is $12M; the company was selected in October 2025 for the GenAI Fund/NVIDIA FastTrack AI Accelerator.

Name

LIFEAI LTD

Legal name

LIFE AI Foundation

Website

https://lifeai.io

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

51–100 employees

Short description

LIFE AI operates the Biohub, an AI-native healthcare infrastructure platform that unifies genetic, biomarker, and real-world health data for pharmaceutical companies, hospitals, research institutions, and consumers across seven Asian countries plus the US.

Ownership category

akta.pro rank

Product category

Healthcare AI Infrastructure

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Software Publishers (51321)

SIC

Services-Prepackaged Software (7372), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)

akta.pro secondary industries

Bioinformatics & Multi-omics Analysis Software (HLAGAJAD), Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)

Keywords

• Healthcare AI infrastructure
• Genomic data platform
• Precision health solutions
• Blockchain genomics
• Real-world health data

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Genetic Testing Services: Life AI facilitates user access to genetic testing and personalized health analysis services provided by licensed partners such as Genetica. Services include new genetic testing packages for first-time users and unlock packages for existing users expanding previously analyzed genetic data. VIP Membership (earned through 3+ genetic testing purchases) receives 30% discount on subsequent services.
2. AI Model-as-a-Service (Infrastructure): LIFE AI provides AI infrastructure to organizations enabling them to launch life science products faster and at lower cost. Organizations access the Biohub infrastructure to build precision health products, drug discovery platforms, and personalized prevention programs. Revenue from infrastructure access and platform services.
3. Membership Tiers: Two membership tiers: Regular Member (free, basic services) and VIP Member (earned through activity, no upfront fee). VIP achieved by purchasing 3 genetic testing services, entitled to 30% discount on subsequent genetic testing. Life Points earned for community participation can be used for internal rewards but have no financial value.
4. Enterprise Partnerships: Revenue from enterprise partnerships with pharmaceutical companies and hospitals. Kalbe Farma partnership enables personalized stroke prevention product deployment. Partnerships with research institutions for validated studies. Co-development revenue from helping pharma/biotech companies compress development cycles.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

LIFE AI builds the Biohub, an AI-powered infrastructure layer that integrates artificial intelligence, genetic technology, blockchain-based data ownership (Gene NFTs), and real-world health data from 550,000+ humans. It offers pharmaceutical companies, hospitals, research institutions, and health-tech builders a coordination platform to compress healthcare R&D timelines and costs, while serving individual consumers through the LIFE App super app for genetic testing and personalized health.

Product overview

LIFE AI operates a unified platform ecosystem built on the Biohub infrastructure, which integrates AI capabilities, biotech innovation, and human participation to coordinate real-world health dynamics. The platform consists of the core Biohub infrastructure with multiple specialized subnets: Genetica (genetics/genomics), Prevana (preventive healthcare), Life Cloud (data management), Life Unity (community engagement), and InfiniteLife (longevity). The LIFE App serves as the primary user-facing super app, integrating multiple mini-applications. Additional offerings include Genetic Testing Services and Life Points (internal reward system). The StrokeGENME product exemplifies how external partners build on the Biohub to create specialized health applications.

Differentiator

Problem solved

Functional benefit

Brands

• Biohub: AI-powered Biohub infrastructure layer integrating AI capabilities, biotech innovation, and human participation in one infrastructure layer for human health.
• Life Unity
• Prevana
• Life Cloud

Products and services

• LIFE AI Biohub Core infrastructure platform that integrates AI capabilities, biotech innovation, and human participation into a single coordination layer. Provides access to health trajectories from 550,000+ humans, AI pattern recognition, validated identity (110,000+ identities), and 15+ petabytes of real-world health intelligence for enterprise clients.
• LIFE App

Quantifiable outcome

• Research validation reduced from 24 months to 6 weeks (16× compression)
• +4 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature6 records

Partnerships

Eight partnerships are on record, tiered core and strategic.

• Volunteer Medical Association (VMA) ThailandcoreStrategic or Co-development Partner · 12 January 2026Thailand's largest medical volunteer organization partnering for PREVANA subnet deployment. VMA operates a nationwide network of volunteer healthcare providers reaching both urban centers and remote rural areas throughout Thailand. This extends the infrastructure's reach across urban centers and remote areas, amplifying the impact each provider can have while maintaining trusted human presence throughout the preventative lifecare journey.
• Kalbe FarmacoreStrategic or Co-development Partner · 11 December 2025Southeast Asia's largest pharmaceutical company partnered with Life AI to launch StrokeGENME, a genetics-powered platform translating DNA insights into individualized stroke-prevention plans. Kalbe Farma serves millions through its extensive national network in medicine, diagnostics, and clinical services. Indonesia's largest healthcare enterprise with industry-leading capabilities in branding, distribution, finance, and R&D. The partnership enables 10x-30x reduction in development costs for personalized cardiovascular innovation.
• GenAI Fund and NVIDIA Inception ProgramcoreTechnology or Integration · 27 October 2025Life AI selected to join first-ever FastTrack AI Accelerator Cohort 1 - powered by GenAI Fund and accelerated by NVIDIA. Program provides access to GPU resources, technical support by NVIDIA experts, enterprise PoC opportunities through GenAI Open Invitation Network, investment evaluation and founding opportunities. 12-week program with compute power of up to $1M.
• SOL Corporation InternationalstrategicStrategic or Co-development Partner · 29 November 2024Strategic partnership with SOL Corporation International, a prominent healthcare company in Asia, to bring precision medicine powered by genetic decoding technology to billions of people. SOL Corporation aims to bring protective and healthcare solutions using Nano Gold products. SOL views Life AI as key enabler for traditional Web2 companies to transition into Web3 ecosystem.
• Stanford, Cornell, UCSF ResearcherscoreStrategic or Co-development PartnerResearch collaborations with scientists from Stanford, Cornell, and UCSF contributing to platform development and validation. Part of 100+ corporate and institutional partners. These academic partnerships provide scientific rigor and validation for the Biohub infrastructure.
• Hue Central HospitalcoreStrategic or Co-development PartnerVietnam's leading hospital conducted Southeast Asia's largest autism genetics study on Life AI infrastructure. Study published in a top-tier journal for 25× lower cost than traditional research pathways. Cost reduced from $250K to $10K. Demonstrates infrastructure capability for major research initiatives.
• GeneticacoreTechnology or IntegrationLicensed partner providing genetic testing services including new genetic testing packages for first-time users and unlock packages for existing users. Genetica has created Southeast Asia's largest native genetic dataset with 99%+ decoding accuracy. Provided over 2 million personalized health recommendations.
• Southeast Asia Hospital NetworkcoreStrategic or Co-development PartnerVast hospital network across Asia as part of 100+ corporate and institutional partners. Network enables research validation, product distribution, and real-world health data access. Supports deployment of precision health products at scale.

Scale indicators12 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• 23andMe: Consumer-facing genetic testing and genomics platform with aggregated DNA data from millions of users for research and therapeutics. Closely comparable to Life AI's Genetica subnet in genetic testing, though 23andMe lacks the AI infrastructure layer and Asian market focus.
• Color Health: Genomics and preventive health platform offering genetic testing combined with clinical decision support for population-scale screening programs. Comparable to Life AI's PREVANA subnet in deploying preventive genetics at scale through enterprise health partnerships.
• Nebula Genomics: Blockchain-based decentralized genomics platform using cryptographic techniques to give users ownership of their genomic data. The most direct peer to Life AI's Gene NFT architecture and data-sovereignty positioning, though Nebula focuses on whole-genome sequencing rather than infrastructure.
• Helix: DNA sequencing and population genomics platform powering health systems and research through its proprietary Exome+ assay. Comparable to Life AI in providing genomics-as-infrastructure to partners and building data networks from consented consumer samples.

Regional players

• iCarbonX: China-based AI health data platform combining multi-omics, lifestyle, and clinical data to build digital health profiles. Comparable to Life AI's multi-omics integration thesis and AI-driven pattern recognition, operating in an adjacent Asian geography.

Emerging players

• Medable: Decentralized clinical trial platform that accelerates research timelines by enabling remote participation and real-world data capture. Comparable to Life AI's research acceleration value proposition (Hue Central Hospital autism study), focused specifically on clinical trials.
• Phenome Health: Non-profit building a large-scale multi-omics and health outcomes dataset for AI-driven discovery. Closely comparable to Life AI in mission-driven structure, multi-omics data accumulation, and emphasis on real-world health dynamics for research acceleration.

Broad incumbents

• Tempus AI: AI-powered precision medicine platform combining large-scale clinical and molecular data to accelerate drug discovery and personalized care. Direct overlap with Life AI's Biohub in multi-omics data aggregation and pharma enablement, but Tempus operates at much larger scale with deeper US payer/pharma relationships.
• IQVIA: Global clinical research and real-world evidence provider serving pharma with data, technology, and analytics. Comparable to Life AI as an enterprise data-and-AI infrastructure layer for pharma research, with far larger scale, broader services, and global footprint.
• Verily (Alphabet): Alphabet's life sciences and health data platform combining AI, real-world evidence, and precision health interventions. Comparable to Life AI's Biohub as an AI-driven health infrastructure platform, with vastly greater resources and broader scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/LifeNetwork_AI

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LIFEAI LTD